Stonebridge Capital Advisors’s MaxLinear MXL Stock Holding History

Stonebridge Capital Advisors’s Portfolio MXL Stock Details MXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-8	Closed	–	–	1061
2022 Q3	$0	Buy	+8	New	+$296	﹤0.01%	1078

Other funds holding MXL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Channing Capital Management Chicago, Illinois $4.34B AUM 37.08% 1-Year Est. Return

Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Stonebridge Capital Advisors's MXL Position: Q4 2022 in Review

Stonebridge Capital Advisors sold out of MaxLinear (MXL) in Q4 2022, closing a stake of 8 shares.

Stonebridge Capital Advisors first reported a position in MXL in Q3 2022 and held it in 1 quarter. The position peaked at $0 in Q3 2022. 280 funds tracked by Wall St. Rank hold MXL as of Q4 2022.

Stonebridge Capital Advisors reported no remaining MaxLinear position as of Q4 2022 after selling out during the quarter.
Stonebridge Capital Advisors sold 8 MaxLinear shares in Q4 2022.
Stonebridge Capital Advisors first reported a position in MaxLinear in Q3 2022 and held it in 1 quarter.
Stonebridge Capital Advisors's MaxLinear position peaked at $0 in Q3 2022.
280 funds tracked by Wall St. Rank held MaxLinear as of Q4 2022.

Based on Stonebridge Capital Advisors's 13F filing for Q4 2022, filed 14 Feb 2023.